(Q41310701)

29 September 2017

title

Enhancement of phenytoin elimination by multiple-dose activated charcoal (English)

1 reference

29 September 2017

1 reference

1 reference

Mauro LS

1

1 reference

29 September 2017

Mauro VF

series ordinal

2

1 reference

29 September 2017

Brown DL

series ordinal

3

1 reference

29 September 2017

Somani P

series ordinal

4

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 October 1987

1 reference

Annals of Emergency Medicine

29 September 2017

published in

1 reference

29 September 2017

volume

16

1 reference

29 September 2017

issue

10

1 reference

29 September 2017

page(s)

1132-1135

1 reference

Diphenylhydantoin elimination kinetics in overdosed children

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Charcoal hemoperfusion in the therapy for methsuximide and phenytoin overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Acute dilantin poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Acceleration of the body clearance of phenobarbital by oral activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Enhancement of theophylline clearance by oral activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Acceleration of digoxin clearance by activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Phenytoin: Pharmacokinetics and bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Computational problems of compartment models with michaelis-menten-type elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Inheritance of phenytoin hypometabolism: a kinetic study of one family

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Metabolic disposition of diphenylhydantoin in normal human subiects following intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Phenytoin Tolerance Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

The rate of decline of diphenylhydantoin in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Gastrointestinal clearance of drugs with activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980471-7

7 January 2021

10.1016/S0196-0644(87)80471-7

Identifiers

DOI

1 reference

29 September 2017

1 reference